195940 — HK inno.N Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for HK inno.N, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	539,908	598,447	769,786	846,522	828,908
Cost of Revenue
Gross Profit	298,791	323,842	317,915	349,424	375,967
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	466,855	520,977	719,463	794,483	768,289
Operating Profit	73,052	77,470	50,323	52,039	60,619
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	30,704	53,093	27,785	37,818	45,166
Provision for Income Taxes
Net Income After Taxes	13,217	27,897	24,736	38,134	47,199
Net Income Before Extraordinary Items
Net Income	13,217	27,897	24,736	38,134	47,199
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13,217	27,897	24,736	38,134	47,199
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	452	1,150	988	1,363	1,785
Dividends per Share